Boston Therapeutics Inc BTHE Company Overview
Boston Therapeutics Inc BTHE Current Price and Quotes
Last Price 1.25
Previous Close 1.39 Open 1.25
Daily Range 1.25 - 1.25 52wk Range 1.65 - 0.15
Volume 1,460 Dividend N/A
Average Vol (3m) 20,168 Yield N/A
BTHE Stock Message Board http://investorshangout.com/search?q=BTHE&...mp;yt1=Go!
Last Updated: Sunday, October 27, 2013 02:38:27 AM
Boston Therapeutics Inc BTHE
Company Verified Profile
Company Information
1750 Elm Street
Manchester, NH 03104
Website: http://www.bostonti.com
Phone: 603-935-9799
Email: info@bostonti.com
Boston Therapeutics Inc BTHE
Boston Therapeutics, headquartered in Manchester, NH, (OTCQB: BTHE) is a leader in the field of designing drugs using complex carbohydrates. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including: PAZ320, a non-systemic chewable compound designed to reduce post-meal glucose elevation, and IPOXYN, an injectable anti-necrosis drug specifically designed to treat lower limb ischemia associated with diabetes. More information is avai...
Boston Therapeutics Inc BTHE
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001473579
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Mar 26, 2012
Incorporated In: DE, USA
Year of Inc. 2009
Employees Not Available
Company Officers/Contacts
David Platt CEO, CFO
Anthony Squeglia CFO
Company Directors
Not Available
Service Providers
Auditor/Accountant
Mcgladrey & Pullen LLP (MA)
80 City Square
Boston, MA, 02129
United States
Legal Counsel
Seyfarth Shaw LLP
Two Seaport Lane
Boston, MA, 02210
United States
Investor Relations Firm
DGI Investor Relations, Inc.
75 Maiden Lane
New York, NY, 10038
United States
Boston Therapeutics Inc BTHE
BTHE Security Details
Share Structure
Market Value1 $24,229,424 a/o Oct 25, 2013
Shares Outstanding 19,383,539 a/o Jul 23, 2013
Float 2,309,118 a/o May 18, 2012
Authorized Shares 100,000,000 a/o Sep 30, 2011
Par Value 0.001
Shareholders
Shareholders of Record 1,678 a/o Apr 04, 2013
Short Selling Data
Short Interest 0 (-100%)
May 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Worldwide Stock Transfer, LLC
Boston Therapeutics Inc BTHE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 42 4 -
Cost of Revenue 57 6 -
Gross Profit (15) (2) -
Operating Expenses
Research and Development 179 194 11
Sales, General and Admin. 1,269 615 230
Non-Recurring Items - - -
Other - - -
Operating Income (1,463) (812) (241)
Income From Continuing Operations
Add'l Income/Expense Items (3) - -
Earnings Before Interest and Tax (1,466) (812) (241)
Interest Expense 18 16 7
Earnings Before Tax (1,484) (827) (248)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (1,484) (827) (248)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (1,484) (827) (248)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (1,484) (827) (248)
Boston Therapeutics Inc BTHE Recent News
Oct 16, 2013 Boston Therapeutics to Present at the Livingston Securities Advanced and Nano Life Sciences Summit
Oct 15, 2013 Boston Therapeutics Initiates Research Study on PAZ320 at University of Minnesota
Oct 7, 2013 Systemic Versus Non-Systemic Diabetes Drugs
Oct 7, 2013 Helping People with Diabetes Block the Bad Carbs
Oct 3, 2013 Boston Therapeutics Closes $5.3 Million in Private Placement of Common Stock and Warrants
Sep 9, 2013 Boston Therapeutics Closes on Approximately $3.5 Million in Private Placement of Common Stock and Warrants
Sep 4, 2013 Boston Therapeutics Reports Positive Phase II Results of PAZ320 Are Published in July/August Issue of Endocrine Practice
Aug 9, 2013 Boston Therapeutics Reports Financial Results and Corporate Update for the Second Quarter and Six Months Ended June 30, 2013
Aug 2, 2013 Boston Therapeutics to Exhibit at 2013 American Association of Diabetes Educators Annual Meeting & Exhibition in Philadelphia
BTHE Boston Therapeutics Inc Research DD Guide
Stock Message Board http://investorshangout.com/search?q=BTHE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BTHE/quote
Stock Chart http://www.otcmarkets.com/stock/BTHE/chart
Company Info http://www.otcmarkets.com/stock/BTHE/company-info
Recent News http://www.otcmarkets.com/stock/BTHE/news
Financials http://www.otcmarkets.com/stock/BTHE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BTHE/filings
Short Sales http://www.otcmarkets.com/stock/BTHE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BTHE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BTHE/research
Summary http://finance.yahoo.com/q?s=BTHE
Historical Prices http://finance.yahoo.com/q/hp?s=BTHE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BTHE
Basic Chart http://finance.yahoo.com/q/bc?s=BTHE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BTHE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BTHE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BTHE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BTHE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BTHE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BTHE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BTHE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BTHE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BTHE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BTHE
Balance Sheet http://finance.yahoo.com/q/bs?s=BTHE
Cash Flow http://finance.yahoo.com/q/cf?s=BTHE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BTHE
Market Watch http://www.marketwatch.com/investing/stock/BTHE
Bloomberg http://www.bloomberg.com/quote/BTHE:US
Morningstar http://quotes.morningstar.com/stock/s?t=BTHE
Bussinessweek http://investing.businessweek.com/research/st...icker=BTHE
Barchart http://www.barchart.com/quotes/stocks/BTHE
OTC Short Report http://otcshortreport.com/index.php?index=BTHE
Investopedia http://www.investopedia.com/markets/stocks/BTHE/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Boston Therapeutics Inc BTHE Current Price and Quotes
Last Price 1.25
Previous Close 1.39 Open 1.25
Daily Range 1.25 - 1.25 52wk Range 1.65 - 0.15
Volume 1,460 Dividend N/A
Average Vol (3m) 20,168 Yield N/A
BTHE Stock Message Board http://investorshangout.com/search?q=BTHE&...mp;yt1=Go!
Last Updated: Sunday, October 27, 2013 02:38:27 AM
Boston Therapeutics Inc BTHE
Company Verified Profile
Company Information
1750 Elm Street
Manchester, NH 03104
Website: http://www.bostonti.com
Phone: 603-935-9799
Email: info@bostonti.com
Boston Therapeutics Inc BTHE
Boston Therapeutics, headquartered in Manchester, NH, (OTCQB: BTHE) is a leader in the field of designing drugs using complex carbohydrates. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including: PAZ320, a non-systemic chewable compound designed to reduce post-meal glucose elevation, and IPOXYN, an injectable anti-necrosis drug specifically designed to treat lower limb ischemia associated with diabetes. More information is avai...
Boston Therapeutics Inc BTHE
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001473579
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Mar 26, 2012
Incorporated In: DE, USA
Year of Inc. 2009
Employees Not Available
Company Officers/Contacts
David Platt CEO, CFO
Anthony Squeglia CFO
Company Directors
Not Available
Service Providers
Auditor/Accountant
Mcgladrey & Pullen LLP (MA)
80 City Square
Boston, MA, 02129
United States
Legal Counsel
Seyfarth Shaw LLP
Two Seaport Lane
Boston, MA, 02210
United States
Investor Relations Firm
DGI Investor Relations, Inc.
75 Maiden Lane
New York, NY, 10038
United States
Boston Therapeutics Inc BTHE
BTHE Security Details
Share Structure
Market Value1 $24,229,424 a/o Oct 25, 2013
Shares Outstanding 19,383,539 a/o Jul 23, 2013
Float 2,309,118 a/o May 18, 2012
Authorized Shares 100,000,000 a/o Sep 30, 2011
Par Value 0.001
Shareholders
Shareholders of Record 1,678 a/o Apr 04, 2013
Short Selling Data
Short Interest 0 (-100%)
May 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Worldwide Stock Transfer, LLC
Boston Therapeutics Inc BTHE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 42 4 -
Cost of Revenue 57 6 -
Gross Profit (15) (2) -
Operating Expenses
Research and Development 179 194 11
Sales, General and Admin. 1,269 615 230
Non-Recurring Items - - -
Other - - -
Operating Income (1,463) (812) (241)
Income From Continuing Operations
Add'l Income/Expense Items (3) - -
Earnings Before Interest and Tax (1,466) (812) (241)
Interest Expense 18 16 7
Earnings Before Tax (1,484) (827) (248)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (1,484) (827) (248)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (1,484) (827) (248)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (1,484) (827) (248)
Boston Therapeutics Inc BTHE Recent News
Oct 16, 2013 Boston Therapeutics to Present at the Livingston Securities Advanced and Nano Life Sciences Summit
Oct 15, 2013 Boston Therapeutics Initiates Research Study on PAZ320 at University of Minnesota
Oct 7, 2013 Systemic Versus Non-Systemic Diabetes Drugs
Oct 7, 2013 Helping People with Diabetes Block the Bad Carbs
Oct 3, 2013 Boston Therapeutics Closes $5.3 Million in Private Placement of Common Stock and Warrants
Sep 9, 2013 Boston Therapeutics Closes on Approximately $3.5 Million in Private Placement of Common Stock and Warrants
Sep 4, 2013 Boston Therapeutics Reports Positive Phase II Results of PAZ320 Are Published in July/August Issue of Endocrine Practice
Aug 9, 2013 Boston Therapeutics Reports Financial Results and Corporate Update for the Second Quarter and Six Months Ended June 30, 2013
Aug 2, 2013 Boston Therapeutics to Exhibit at 2013 American Association of Diabetes Educators Annual Meeting & Exhibition in Philadelphia
BTHE Boston Therapeutics Inc Research DD Guide
Stock Message Board http://investorshangout.com/search?q=BTHE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BTHE/quote
Stock Chart http://www.otcmarkets.com/stock/BTHE/chart
Company Info http://www.otcmarkets.com/stock/BTHE/company-info
Recent News http://www.otcmarkets.com/stock/BTHE/news
Financials http://www.otcmarkets.com/stock/BTHE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BTHE/filings
Short Sales http://www.otcmarkets.com/stock/BTHE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BTHE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BTHE/research
Summary http://finance.yahoo.com/q?s=BTHE
Historical Prices http://finance.yahoo.com/q/hp?s=BTHE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BTHE
Basic Chart http://finance.yahoo.com/q/bc?s=BTHE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BTHE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BTHE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BTHE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BTHE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BTHE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BTHE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BTHE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BTHE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BTHE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BTHE
Balance Sheet http://finance.yahoo.com/q/bs?s=BTHE
Cash Flow http://finance.yahoo.com/q/cf?s=BTHE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BTHE
Market Watch http://www.marketwatch.com/investing/stock/BTHE
Bloomberg http://www.bloomberg.com/quote/BTHE:US
Morningstar http://quotes.morningstar.com/stock/s?t=BTHE
Bussinessweek http://investing.businessweek.com/research/st...icker=BTHE
Barchart http://www.barchart.com/quotes/stocks/BTHE
OTC Short Report http://otcshortreport.com/index.php?index=BTHE
Investopedia http://www.investopedia.com/markets/stocks/BTHE/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
